The life science sector is permanently evolving, but a moment of reckoning has arrived.

This white paper is a call to action for everyone - scientists, investors, entrepreneurs, and patients alike. We must unite and invest in solutions that combat resistant bacteria before they become unstoppable.

This new white paper, The Reckoning of Antimicrobial Resistance, A new biological frontier, will explore the current AMR threat, touch on challenges and opportunities regarding ongoing drug development efforts, share light on innovative approaches concerning microbiome and phage therapeutics, and depict the current landscape of AMR R&D.

Download your copy and learn from diverse experts and their insightful contributions on why AMR demands immediate attention.

In this resource, we discuss:

  • The urgent need for collective action against AMR
  • How innovators and entrepreneurs can play a crucial role
  • The power of collaboration and shared intelligence